• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用人骨髓和脂肪组织来源的间充质干细胞、成人及胎儿关节软骨来源的软骨细胞以及软骨祖细胞对软骨缺损修复的比较评估:一种体外模型

Comparative assessment of chondral defect repair using human bone marrow- and adipose tissue-derived mesenchymal stem cells, adult and foetal articular cartilage-derived chondrocytes, and chondroprogenitors: an ex-vivo model.

作者信息

Vinod Elizabeth, Parasuraman Ganesh, J Jeya Lisha, Varghese Jithu James, Livingston Abel, Rebekah Grace, Francis Deepak Vinod, Sathishkumar Solomon, Daniel Alfred Job, Ramasamy Boopalan

机构信息

Department of Physiology, Christian Medical College, Vellore, Tamil Nadu, 632002, India.

Centre for Stem Cell Research (A Unit of InStem, Bengaluru), Christian Medical College, Vellore, India.

出版信息

Biotechnol Lett. 2025 Jan 8;47(1):17. doi: 10.1007/s10529-024-03558-0.

DOI:10.1007/s10529-024-03558-0
PMID:39775982
Abstract

PURPOSE

Cartilage repair necessitates adjunct therapies such as cell-based approaches, which commonly use MSCs and chondrocytes but is limited by the formation of fibro-hyaline cartilage. Articular cartilage-derived chondroprogenitors(CPs) offer promise in overcoming this, as they exhibit higher chondrogenic and lower hypertrophic phenotypes. The study aimed to compare the efficacy of various cell types derived from adult and foetal cartilage suspended in platelet-rich plasma(PRP) in repairing chondral defects in an Ex-vivo Osteochondral Unit(OCU) model.

METHODS

In-vitro characterization of the cells included growth kinetics, FACS, qRT-PCR, and multilineage differentiation potential using histology and GAG analysis. Ex-vivo human OCUs with chondral defects containing the different cells in PRP were cultured and subjected to analysis for matrix and collagen staining.

RESULTS

The ex-vivo OCU analysis, in terms of defect repair, showed that adult chondrocytes, sorted-CPs, and foetal MCPs displayed better host integration and filling. The In-vitro analysis of adult chondrocytes displayed greater chondrogenic genes ACAN and COL2A1 expression, with sorted-CPs also showing higher levels of ACAN. In terms of accumulation of extracellular matrix uptake evident by Safranin O staining and collagen type II fibrillar uptake, the AD-MSCs, BM-MSCs, and sorted CPs outperformed the other groups. BM-MSCs also showed corroborative higher CD146 levels, however, the gene analysis of the AD-MSCs showed a high hypertrophic tendency in terms of its COL1A1 and RUNX2 expression.

CONCLUSION

Sorted chondroprogenitors outperformed both in terms of filling and hyaline-like repair, with AD-MSC and BM-MSC groups also achieving functional cartilage of a hyaline nature, warranting further evaluation using in-vivo and clinical studies.

摘要

目的

软骨修复需要辅助治疗,如基于细胞的方法,该方法通常使用间充质干细胞(MSCs)和软骨细胞,但受纤维透明软骨形成的限制。关节软骨来源的软骨祖细胞(CPs)有望克服这一问题,因为它们表现出更高的软骨生成和更低的肥大表型。本研究旨在比较悬浮于富血小板血浆(PRP)中的成人和胎儿软骨来源的各种细胞类型在体外骨软骨单元(OCU)模型中修复软骨缺损的效果。

方法

细胞的体外特性包括生长动力学、流式细胞术(FACS)、定量逆转录聚合酶链反应(qRT-PCR),以及使用组织学和糖胺聚糖(GAG)分析的多谱系分化潜能。对含有PRP中不同细胞的体外人OCU软骨缺损进行培养,并进行基质和胶原染色分析。

结果

就缺损修复而言,体外OCU分析表明,成人软骨细胞、分选的CPs和胎儿间充质软骨祖细胞(MCPs)表现出更好的宿主整合和填充。成人软骨细胞的体外分析显示软骨生成基因ACAN和COL2A1表达更高,分选的CPs也显示出更高水平的ACAN。就番红O染色和II型胶原纤维摄取所显示的细胞外基质摄取积累而言,脂肪来源的MSCs(AD-MSCs)、骨髓来源的MSCs(BM-MSCs)和分选的CPs优于其他组。BM-MSCs也显示出更高的CD146水平,然而,AD-MSCs的基因分析显示其COL1A1和RUNX2表达具有较高的肥大倾向。

结论

分选的软骨祖细胞在填充和类透明软骨修复方面均表现出色,AD-MSC和BM-MSC组也实现了透明软骨性质的功能性软骨,值得通过体内和临床研究进行进一步评估。

相似文献

1
Comparative assessment of chondral defect repair using human bone marrow- and adipose tissue-derived mesenchymal stem cells, adult and foetal articular cartilage-derived chondrocytes, and chondroprogenitors: an ex-vivo model.使用人骨髓和脂肪组织来源的间充质干细胞、成人及胎儿关节软骨来源的软骨细胞以及软骨祖细胞对软骨缺损修复的比较评估:一种体外模型
Biotechnol Lett. 2025 Jan 8;47(1):17. doi: 10.1007/s10529-024-03558-0.
2
Comparative assessment of chondral defect repair using migratory chondroprogenitors suspended in either gelled or freeze-dried platelet-rich plasma: An in vitro and ex vivo human osteochondral unit model study.应用悬浮于凝胶或冻干富血小板血浆中的迁移性软骨祖细胞修复软骨缺损的对比评估:体外和体外人骨软骨单位模型研究。
Knee. 2024 Jun;48:105-119. doi: 10.1016/j.knee.2024.03.006. Epub 2024 Apr 1.
3
Comparative analysis of human bone marrow mesenchymal stem cells, articular cartilage derived chondroprogenitors and chondrocytes to determine cell superiority for cartilage regeneration.比较分析人骨髓间充质干细胞、关节软骨来源的软骨祖细胞和软骨细胞,以确定用于软骨再生的细胞优势。
Acta Histochem. 2021 May;123(4):151713. doi: 10.1016/j.acthis.2021.151713. Epub 2021 Apr 21.
4
Migratory chondroprogenitors retain superior intrinsic chondrogenic potential for regenerative cartilage repair as compared to human fibronectin derived chondroprogenitors.与源自人纤维连接蛋白的软骨祖细胞相比,迁移性软骨祖细胞保持了优越的内在软骨生成潜力,可用于再生性软骨修复。
Sci Rep. 2021 Dec 8;11(1):23685. doi: 10.1038/s41598-021-03082-5.
5
Effect of Platelet-Rich Plasma on Chondrogenic Differentiation of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells.富血小板血浆对脂肪源性和骨髓源性间充质干细胞向软骨细胞分化的影响。
Tissue Eng Part A. 2018 Oct;24(19-20):1432-1443. doi: 10.1089/ten.tea.2018.0065. Epub 2018 Jul 23.
6
Allogeneic platelet rich plasma serves as a scaffold for articular cartilage derived chondroprogenitors.异体富血小板血浆可作为关节软骨来源的软骨祖细胞的支架。
Tissue Cell. 2019 Feb;56:107-113. doi: 10.1016/j.tice.2018.12.006. Epub 2019 Jan 2.
7
Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.马骨髓间充质干细胞的特性及其在马软骨工程中的应用。研究在 BMP-2 和 TGF-ß1 存在的情况下,在生物材料中于低氧条件下培养时其形成透明软骨的潜力。
Stem Cell Rev Rep. 2017 Oct;13(5):611-630. doi: 10.1007/s12015-017-9748-y.
8
Chondrogenic Progenitor Cells Exhibit Superiority Over Mesenchymal Stem Cells and Chondrocytes in Platelet-Rich Plasma Scaffold-Based Cartilage Regeneration.富血小板血浆支架软骨再生中,软骨祖细胞优于间充质干细胞和软骨细胞。
Am J Sports Med. 2019 Jul;47(9):2200-2215. doi: 10.1177/0363546519854219. Epub 2019 Jun 13.
9
Matrigel-encapsulated articular cartilage derived fibronectin adhesion assay derived chondroprogenitors for enhanced chondrogenic differentiation: An in vitro evaluation.基质胶包封的关节软骨源性纤连蛋白黏附试验衍生的软骨祖细胞促进软骨生成分化:一项体外评估
Tissue Cell. 2025 Feb;92:102638. doi: 10.1016/j.tice.2024.102638. Epub 2024 Nov 26.
10
Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage.骨关节炎关节软骨细胞和健康供体间充质干细胞在关节软骨组织工程中的相似特性。
PLoS One. 2013 May 9;8(5):e62994. doi: 10.1371/journal.pone.0062994. Print 2013.

引用本文的文献

1
Comparative assessment of human chondroprogenitor viability and molecular phenotype in various parenteral transport media.不同肠胃外输送介质中人类软骨祖细胞活力和分子表型的比较评估
Histochem Cell Biol. 2025 Aug 20;163(1):82. doi: 10.1007/s00418-025-02416-y.

本文引用的文献

1
Human fetal cartilage-derived chondrocytes and chondroprogenitors display a greater commitment to chondrogenesis than adult cartilage resident cells.人胎儿软骨来源的软骨细胞和软骨祖细胞比成年软骨固有细胞具有更大的软骨生成潜力。
PLoS One. 2023 Apr 27;18(4):e0285106. doi: 10.1371/journal.pone.0285106. eCollection 2023.
2
Systematic review of articular cartilage derived chondroprogenitors for cartilage repair in animal models.动物模型中用于软骨修复的关节软骨来源软骨祖细胞的系统评价
J Orthop. 2022 Nov 3;35:43-53. doi: 10.1016/j.jor.2022.10.012. eCollection 2023 Jan.
3
Osteochondral explants for diarthrodial joint diseases: bridging the gap between bench and bedside.
用于关节疾病的软骨-骨组织块:缩小基础研究与临床治疗的差距。
Eur Cell Mater. 2022 Sep 26;44:74-89. doi: 10.22203/eCM.v044a05.
4
The Current Status of Clinical Trials on Biologics for Cartilage Repair and Osteoarthritis Treatment: An Analysis of ClinicalTrials.gov Data.生物制剂治疗软骨修复和骨关节炎的临床试验现状:对 ClinicalTrials.gov 数据的分析。
Cartilage. 2022 Apr-Jun;13(2):19476035221093065. doi: 10.1177/19476035221093065.
5
Safety and efficacy of adipose-derived mesenchymal stem cells for knee osteoarthritis: A systematic review and m-analysis.脂肪间充质干细胞治疗膝骨关节炎的安全性和有效性的系统评价和荟萃分析。
Joint Bone Spine. 2022 Oct;89(5):105404. doi: 10.1016/j.jbspin.2022.105404. Epub 2022 May 6.
6
Adipose Tissue-Derived Mesenchymal Stem Cells as a Potential Restorative Treatment for Cartilage Defects: A PRISMA Review and Meta-Analysis.脂肪组织来源的间充质干细胞作为软骨缺损潜在修复治疗方法的PRISMA综述与荟萃分析
Pharmaceuticals (Basel). 2021 Dec 8;14(12):1280. doi: 10.3390/ph14121280.
7
Migratory chondroprogenitors retain superior intrinsic chondrogenic potential for regenerative cartilage repair as compared to human fibronectin derived chondroprogenitors.与源自人纤维连接蛋白的软骨祖细胞相比,迁移性软骨祖细胞保持了优越的内在软骨生成潜力,可用于再生性软骨修复。
Sci Rep. 2021 Dec 8;11(1):23685. doi: 10.1038/s41598-021-03082-5.
8
Cell therapy for cartilage repair.细胞治疗软骨修复。
Emerg Top Life Sci. 2021 Oct 29;5(4):575-589. doi: 10.1042/ETLS20210015.
9
Mesenchymal Stem Cells in the Treatment of Cartilage Defects of the Knee: A Systematic Review of the Clinical Outcomes.间质干细胞治疗膝关节软骨缺损:临床疗效的系统评价。
Am J Sports Med. 2021 Nov;49(13):3716-3727. doi: 10.1177/0363546520986812. Epub 2021 Feb 8.
10
Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter.基于 CRISPR-Cas9 生成的报告器鉴定的细胞表面标志物,从人诱导多能干细胞中进行前瞻性分离软骨祖细胞。
Stem Cell Res Ther. 2020 Feb 18;11(1):66. doi: 10.1186/s13287-020-01597-8.